⌘K

Login Start Free

Home/Filings/4/0001179110-12-015715

4//SEC Filing

Metza Kristen 4

Accession 0001179110-12-015715

CIK 0000882095other

View on SEC.gov Company Profile

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 8:26 PM ET

Size

17.4 KB

Accession

0001179110-12-015715

Insider Transaction Report

Form 4

Period: 2012-11-01

GILEAD SCIENCES INCGILD

SVP, Human Resources

Transactions

Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2012-11-01−14,000→ 19,600 total
Exercise: $38.17Exp: 2021-01-20→ Common Stock (14,000 underlying)
Exercise/Conversion
Common Stock
2012-11-01$43.15/sh+2,000$86,300→ 55,305 total
Sale
Common Stock
2012-11-01$68.18/sh−2,800$190,898→ 25,305 total
Exercise/Conversion
Common Stock
2012-11-01$47.51/sh+14,000$665,140→ 53,305 total
Sale
Common Stock
2012-11-01$67.68/sh−27,200$1,840,768→ 28,105 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2012-11-01−2,000→ 3,500 total
Exercise: $43.15Exp: 2018-01-30→ Common Stock (2,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2012-11-01−14,000→ 12,600 total
Exercise: $47.51Exp: 2020-01-28→ Common Stock (14,000 underlying)
Exercise/Conversion
Common Stock
2012-11-01$38.17/sh+14,000$534,380→ 39,305 total

Footnotes (5)

[F1]The exercise and sale transactions are pursuant to a Rule 105b-1 trading plan established by Ms. Metza on February 22, 2011.
[F2]The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
[F3]The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
[F4]Sale prices reported for the transactions reported here range from $67.12 to $68.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
[F5]Sale prices reported for the transactions reported here range from $68.13 to $68.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

GILEAD SCIENCES INC

CIK 0000882095

Entity typeother

Related Parties

1

filerCIK 0001314870

Filing Metadata

Form type: 4
Filed: Nov 4, 7:00 PM ET
Accepted: Nov 5, 8:26 PM ET
Size: 17.4 KB

View on SEC.gov